SARS HIV/AIDS n = 672; % 5% 2% 8% 16% 43% 20%
|
|
- けいしょう まきい
- 5 years ago
- Views:
Transcription
1
2 SARS HIV/AIDS n = 672; % 5% 2% 8% 16% 43% 20%
3 HIV/AIDS B A 0% 50% 100% Taniguchi K, et al. Travel Med Infect Dis 2008;6:
4 38 38 C
5 50% 25% Freedman, et al. N Engl J Med 2006;354: A E
6 > > > ,
7
8 , Salmonella Typhi or Paratyphi A 10~14 WBC "6,700/μ l" Band " "4%" Seg " "78%" Lym " "10%" Mono " "8%" Eosino " "0%" Hb "13.9 g/dl" Hct "38.2 %" Plt "12.7 /μ l" AST " ALT LDH " γgtp T-Bil " BUN Cr Na CRP "305 U/L" "356 U/L" "788 U/L" "161 U/L" 1.9 mg/dl" "15.5 mg/dl" "1.01 mg/dl" "129 meq/l" "10.88 mg/dl"
9 13 GNR S. Typhi or Paratyphi A 800 mg 500 mg 750 mg 2 g 500 mg > > > 1 2
10 99, ,
11 /
12 (n=53) (n=36) (n=16) (n=16) Enterotoxigenic E. coli 18 (33%) 14 (39%) 8 (50%) 3 (19%) EnteroaggregaPve E. coli 11 (20%) 2 (6%) 1 (6%) 1 (6%) Enteropathogenic E. coli 1 (2%) 0 1 (6%) 1 (6%) Salmonella 1 (2%) Campylobacter jejuni 8 (15%) 2 (6%) 2 (13%) 0 Shigella spp. 3 (6%) 4 (11%) 1 (2%) 1 (6%) Vibrio parahaemoly9cus 1 (2%) Cryptosporidium 1 (2%) 1 (3%) 1 (2%) 0 Giardia 0 1 (3%) 0 1 (6%) Norovirus 2 (4%) Rotavirus 3 (6%) 6 (17%) 0 0 Adenovirus 3 (6%) No Pathogen 17 (31%) 9 (25%) 5 (31%) 11 (69%) HUS Shigella, EIEC, EHEC, Salmonella, Vibrio parahaemoly9cus ETEC, EAEC, EPEC, Vibrio cholerae, Salmonella
13 Shigella, STEC Rotavirus, Norovirus, HAV Cryptosporidia, Gialdia, Entamoeba ETEC, EPEC, EAEC, Salmonella, Campylobacter, Vibrio CID 2006 Norfloxacin Ciprofloxacin Ofloxacin Levofloxacin 400 mg 500 mg 200 mg 500 mg A- Azithromycin 1,000 mg B- Rifaximin 200 mg,
14
15
16 STD,,, hispdine- rich protein II, 15
17
18 Askling et al. Malaria J 2012, 11:328 31
19
20 Emerg Infect Dis 9 15 ABCD Awareness of risk Bite prevenpon Chemoprophylaxis Prompt Diagnosis and treatment UK Malaria prevention guideline 2013
21 HP
22 CDC Travelers Health
23
24 incubation period
25 Emerg Infect Dis Emerg Infect Dis Clin Infec Dis
26 (2010) 2000 (2009) 1950 N N N N 100 Km (2000 ( ) JCS III /55 mmhg, 105/, 32/,.. 15,600/μl, CRP 21.8 mg/dl, 400 mmh 2 O,. 1,450/μl, 463 mg/dl, 0 mg/dl.. IASR 2003;24:264
27 8 g/ 4 g / T- 7. IASR 2003;24:
28 13/09/ ARDS Parker AA, et al. N Engl J Med 2005;355: Number of Reported Measles Cases with onset date from Feb to Jul 2013 (6M period) ,000 2,000 3,000 4,000 Miles 0 (73 countries or 38%) 1-9 (21 countries or 11%) (38 countries or 20%) (32 countries or 16%) 1000 (16 countries or 8%) No data reported to WHO HQ (14 countries or 7%) Not applicable Data source: surveillance DEF file Data in HQ as of 09 September 2013 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved.
29 /μl Python cave MHF MARV IgG ELISA 10 nested RT- PCRMARV RNA
30 (n=23) Beeching, et al. Int J Antimicrob Agent (2010)
31 13/09/ /25-3/10 3/153/23 30~50/
32 H5N1 0 H7N SARS
33
34 Required = RouPne Travel Special RouPne CDC Travelers Health FORTH
35 Martin M, et al. Emerg Infect Dis. 2001;7:
36 Travel RouPne
37 A 2010 (IASR;31: , 2010) A (IASR;31: , 2010)
38 hep_b.htm Special Adult Travel
39 MeningiPs- prone area CDC Travelers Health 2013
40 RouPne Adult Vaccines and Boosters, MR
37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate
37, 9-14, 2017 : 36 2015 8 6 cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin 20 1983 2016 3 CD 7 Clostridium difficile CD CD associated diarrhea : CDAD CD 1,2 PPI 3 1 36 33 2015 8 6 5 5
More information_02三浦.indd
36, 7-11, 2016 IPD PCV 5 3 80% 1 invasive pneumococcal disease ; IPD 2010 7 PCV7 2013 13 PCV13 IPD IPD 2,3 2015 1 2015 12 5 1 IPD 2015 1 12 IPD 5 IPD 1 4 2 5 http://pneumocatch.jp/ 5 Statens Serum Institut
More informationsick contact1l
Clinical Question 2017 年 5 月 15 日 分野 : 内分泌テーマ : 治療 19 14 15 18 sick contact1l 170cm/68.8kg, GCSE1V1M5, HR: 120/min, BP: 104/60mmHg, RR: 30/min, SpO 2 : 96%, BT: 38.0 WBC Hb PLT CRP Cr BUN 23400 15.0 35.5
More informationM1 TSH T 3 T 4 2 T 1 2 Plummer 3 TSH TSH K 5 7 TSH TSH Plummer TSH TSH TSH TSH T 4 T 3 TSH T 4 T 3 TSH TSH or Plummer Plummer or a) 1. 2. 3. b) 1. T 4 T 3 2. TSH 0.1 U/ml 3. TSH TRAb TSAb 4. 1) a) 1
More informationBUN, CRP K mg/ cm, 49.6 kg, BMI /72 mmhg, 92/ Hb 6.7 g/dl PT-INR CT 1 MRI 2a, b T1 T2 T1 MRI
20 2 2015 1 2 3 85 K CT Abstract A case of renal subcapsular hematoma resulting from trigger point injection under excessive effect of anticoagulant YAMANE Tateki, UMEDA Akira and SHIMAO Hitoshi An 85-year-old
More informationuntitled
18 12 10 40 H5N1 2005 11 WHO 2005 12 2006 6 (H5N1) 10 25 1,700 ( 1,300 2,500 ) 200 53 64 17 30% 3,785,000 291,200 3 14,100 4 30% 57,600 4,430 3 1,150 320 210 4 2% 0.56% () ) 1 10 2 3A (2B) 3B 4A5A 6A 4B
More information(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32
More information387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )
386 B B () () ( ) ( ) ( ) 387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 388 ( ) ( ) ( ) 389 ( ) 2 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 390 ( ) ( ) ( ) () () ( ) Hot flush 391 ( ) ( ) ( ) 392 ( ( )
More informationindd
18 61 1 2011 症例報告 2010 5 13 2010 12 20 A Case of Varicella with Severe Back Pain in a Patient with Systemic Lupus Erythematosus RIE SAITO, KIORI YANO, FUMIKO KATSUSHIMA, HARUYO IWADATE, HIROKO KOBAYASHI,
More informationデスフルラン
デスフルラン時代の周術期管理 岡山大学麻酔科蘇生科森松博史 デスフルランの特徴!!! 岡山大学での現状 本日のお話 デスフルランの特徴 3 Eger et al. Anesth Analg 1998; 86: 414-21 デスフルランの特徴 2 つのメタアナリシス 2005 Macario et al. Am J Health Syst Pharm!! 2010 Dexter et al.
More informationSBP hospitalist network.key
1 Treatment and Prophylaxis of Spontaneous Bacterial Peritonitis (1); (2), (3). (1) (2) (3) :, :, 2 Clinical Question 1 72...,.,,.,... 3. CT..,. 4? SBP? SBP. 5 Clinical Question SBP? SBP,? 6 SBP (Spontaneous
More information日本呼吸器学会雑誌第44巻第10号
β Table1 Laboratoryfindingsonthefirstvisit Hematology WBC Neut. Lyn. Mon. Eos. Bas. RBC Hb Ht Plate 5,650 /μl 79.2 % 14.9 % 3.9 % 1.8 % 0.2 % 418 10 4 /μl 12.5g/dl 38.4 % 21.2 10 4 /μl Serology CRP IgG
More information香港
FTA CEPA 1970 1980 1980 51 1999 1998 24 2000 2007 2006 11 52 1999 FTA FTA FTA 2001 11 WTO WTO FTA FTA 53 FTA CEPA FTA WTO FTA CEPA 2000 FTA FTA 2000 17 FTA 2000 11 WTO 2000 FTA WTO FTA FTA FTA FTA 2001
More informationuntitled
- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - - 27 - - 28 - - 29 - - 30 -
More information125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10
. (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1
More informationのコピー
70 2001x 9 20 26 27 1 1 2 132/83mmHg 79/ 36.0 1 WBC 6900/mm 3 RBC 432x10 3 /mm 3 Hb 11.8g/dl Hct 39.1 MCV MCH MCHC 90.5fl 27.3pg 30.2g/dl Plt 299x10 3 /mm 3 granulocyte 38% 201x 9 27 S S 2 3 PAS
More information日本呼吸器学会雑誌第48巻第6号
Fig.1 Cutaneousfindingsandpathologicalfindingsofatransbronchiallungbiopsy(TBLB)andlichenifiedeczemaoftherightforearm.Thepatienthadlichenifiedeczemaonhisextremitiesandbodytrunk (1a:rightforearm,1b:leftthigh).Therewasinfiltrationoftheinflammatorylymphocytes,edemaandabrasioninthetype2alveolarepithelium
More information橡ボーダーライン.PDF
1 ( ) ( ) 2 3 4 ( ) 5 6 7 8 9 10 11 12 13 14 ( ) 15 16 17 18 19 20 ( ) 21 22 23 24 ( ) 25 26 27 28 29 30 ( ) 31 To be or not to be 32 33 34 35 36 37 38 ( ) 39 40 41 42 43 44 45 46 47 48 ( ) 49 50 51 52
More information/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 3 2 5/ :90 / :114/64 mmhg
17 2005/12/28 UP 3+, TP 4.2g/dl, Alb 1.9g/dl PSL 50mg/day 1/17 PSL 45mg/day PSL 2006/4/4 PSL 30mg/day mpsl mpsl1000mg 32 5/8 36.1 :90 /:114/64 mmhg 166.2 cm64.3 kg 3.9 g/dl 1.6 g/dl 382 mg/dl 408 mg/dl
More information日本呼吸器学会雑誌第47巻第6号
Fig.1 A,ChestX-rayfilm demonstratingatumorshadow intherightlowerlungfield.b,chestct scan demonstratingtherightmiddlelobemass,measuring9.0 7.3cm.C,AbdominalCT scanshowingfree airintheabdominalcavityanddirtyfatsignaroundthesigmoidcolontumor.
More information_14鈴木.indd
35, 66-71, 2015 hairy cell leukemia Hairy cell leukemia HCL : WHO mature peripheral B - cell neoplasma B 1 2% B T 8% 6-10 2 4 hairy cell 5 10 hairy cell leukemia : 74 : : 20 50 57 63 64 73 : : 2003 4 10
More informationuntitled
1 ... 3... 3... 3... 4...13...16...18...20...22 2 PTPE 3 PTPE CT Grade 2 A PTPE PTPE 4 A S 3 3 B H3,P1,N1,M1, LM0, R23 15 20gS, ptype 3, 60 x 50mm, pt4b/siurinary bladder, int, INF, ly2, v1, ppm070mm,
More information日本呼吸器学会雑誌第44巻第6号
Aspergillus β Table1 Laboratoryfindingsonadmission Hematology WB Seg Band Lymph Eos Baso RB Hb Hct Plt Biochemistry AST ALT LD ALP γ-gtp K 17,700 /mm 3 70.0 % 7.0 % 17.0 % 2.0 % 1.0 % 337 10 4 /mm 3 11.5g/dl
More information日本呼吸器学会雑誌第44巻第7号
Table1Laboratoryfindingsonadmission Hematology Serology LungFunctionTest WBC 7,410 /μl CRP 7.7mg/dl VC 3.12L(97.2%) Neut 66.4 % KL-6 777U/ml FEV1.0 2.35L(78.25%) Eosino 3.2 % PT (INR) 0.94 %DLCO 47.6 %
More information2 W.T T.S. 70 2 1 238 WBC7400/µl, RBC 386 10 4 /µl, Hb 11.6 g/dl, Ht 36.2%, PLT 25 10 4 /µl AST 19 IU/l, ALT 11 IU/l, LDH 182 IU/l, BUN 15 mg/dl, Cr 0.54 mg/dl, CRP6.83 mg/dl, RF 353.9IU/ml, CCP 28.0IU/ml
More informationフィナレビ106号.indb
2009 3 30 2009 4 14 CDC 2009 4 25 WHO 2009 4 26 2009 4 28 2009 4 28 2009 4 30 2009 5 1 2009 5 8 6 2009 5 9 2009 5 23 2009 6 3 2009 6 9 2500 2009 6 12 WHO 6 2009 6 28 2009 8 9 1 1 2009 8 15 2009 8 19 2010
More information2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.
2 章 +αの 情 報 に 着 目 する! 1 血 球 算 定 検 査 結 果 2 生 化 学 検 査 結 果 手 がかりに 乏 しいのも+α 1 症 例 をみてみよう! 1 60 吉 見 祐 輔 1 2 11percutaneous coronary intervention PCI104 38.1 130 75mmHg 83 16 SpO 297 1 3 WBCL RBC10 4 L Hb g
More information400 46 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec. 2012 LVFX 100 mg 3 / 7 150 mg 2 / 7 2 2006 2008 9 LVFX PK PD 2009 7 100 mg 1 3 500 mg 1 1 AUC/MIC
Dec. 2012 THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 399 45 2012 11 5 LVFX 500 mg 1 1 20 Chlamydia trachomatis C. trachomatismycoplasma genitalium M. genitalium LVFX 1 500 mg 1 1 7 22 22 C. trachomatis 17
More informationRinku General Medical Center
Rinku General Medical Center 4860 100 1620 Ann Intern Med. 1966; 64: 328 40 CHOP 63 1 83 J Clin Oncol. 1998; 16: 20065-69 Febrile Neutropenia IDSA(Infectious Diseases Society of America) 2002 Guidelines
More information05/”󄱣Šfiy‰L/08.9
28 Guideline September 2008 Guideline September 2008 29 30 Guideline September 2008 Guideline September 2008 31 32 Guideline September 2008 Guideline September 2008 33 34 Guideline September 2008 Guideline
More information2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742
MJR-35 34 1 1 a MRICT b 2Beecham r-afs 3 4 20 4 mg/ 20 40 5 6 2 1 2 3 44 mg/ 5 6 7 8 4 Gn-RH 742 9 10 11 12 1 20 60 1 1MJR-351 mg/ 0.25 2 Lot. No. 2MJR-352 mg/ 1 1 Lot. No. 3MJR-354 mg/ 1 2 Lot. No. 2
More information溶血性尿毒症症候群 ver 最終.pptx
Hemolytic uremic syndrome(hus) ver0130525 (HUS), Stx VT 3 3 1. ( Hb10g/dl ) 2. ( 10 /µl ) 3. ( 97.5 ) 1.5 ) (HUS) D+HUS D-HUS(aHUS) HUS ahus ( 6 HUS ( ) HUS HUS ahus O-157 9-30 HUS 15 80 5 5 10 2-3 (O-157
More information特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)
VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.
More information小児感染免疫第27巻第4号
2015 小児感染免疫 Vol. 27 No. 4 285 10 1 4 1,2 3 4 10 cat scratch diseasecsd CSD CSD cat scratch diseasecsd Bartonella henselae CSD 30 46 1 CSD B. henselae 21.4 2 7 CSD CSD 10 7 9 9 26 37 40 9 30 CDTR PI 10
More informationValganciclovir 1 CMV valganciclovir VGCV CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovir valganciclovir MRI cytomegaloviru
2012445559 55 Valganciclovir 1 CMVvalganciclovirVGCV 1 21 5 CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovirvalganciclovir MRI cytomegalovirus; CMV TORCH CMV 1 CMV valganciclovirvgcv 21 2 1 1 2 23 37
More information001-029_”÷’X
54 2012 1 29 Kimori Daisuke Kamijo Takashi Takahashi Akira 1993 19951997 2001 10 1993 1999 1992 54 2012 1993 20 LDH BUNCRE UA CPK GOT CPK LDH UA CPK LDH UA CPK 1989 2001 2000 1989 1995 2003 2005 1989 54
More information日本化学療法学会雑誌第66巻第2号
173 Table 1.Detection rates of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Ureaplasma urealyticum, Haemophilus influenzae and adenovirus from male urethritis in Urethritis No.
More informationScanFront300/300P セットアップガイド
libtiff Copyright (c) 1988-1996 Sam Leffler Copyright (c) 1991-1996 Silicon Graphics, Inc. Permission to use, copy, modify, distribute, and sell this software and its documentation for any purpose is hereby
More informationuntitled
Quantitative Risk Assessment on the Public Health Impact of Pathogenic Vibrio parahaemolyticus in Raw Oyster 1 15 5 23 48 2 21 1 16 1 16 1 11 3 1 3 4 23 1 2 16 12 16 5 6 Hazard IdentificationExposure
More informationWBC 5700 / l Gran 58.5% Lym 29.0% Eosin 0.3% RBC 499x10 6 / l Hb 14.8 g/dl Hct 44.40% PLT 15.3x10 3 / l PT 157% Fbg 616 mg/dl DD 0.99 g/ml GOT GPT LDH
54 2002 3 1992 2002 3 2002 7 2004 1 15 4Kg74.0Kg 1 24 80.6 kg BUN 26.0mg/dl, s-cr 2.3mg/dl, 3+ 1 27 40 /34 174.3 cm 80.6 kg 1 10kg36.8 120/70 mmhg 88 / 14 / fibrinogen 616 mg/dl, TP 3.6 g/dl, Alb 1.4 g/dl,
More information2010 年 6 月 25 表 身体所見 134 cm 31 kg /60 mmhg 83/ ,
24 シンポジウム Ⅲ 要旨 NPPV NPPV 緒 IPF 4 5 1 IPF 2004 2 QOL 179 10 現 10 18 2008 10 言 状 3.4 8.3 76.2 41 37.2 13.6 3 1 症 例 呈 示症例 患者 61 主訴 既往歴 30 45 家族歴 喫煙歴 飲酒歴 職歴 現病歴 13 NSIP 15 1 HOT 15 7 2010 年 6 月 25 表 1 1998
More information1996 papilloma virus 2001 Bowen AIHA PSL1mg/kg BMA PRCA parvovirus B19 PVB19 DNA PCR PV IgM 4 PVB19 PRCA MAP PVB19 DNA DNA PR
1996 papilloma virus 2001 Bowen2002 12 2003 2 2002 9 10 AIHA PSL1mg/kg BMAPRCA parvovirus B19 PVB19 DNA PCR PV IgM 4PVB19 PRCA MAPPVB19DNA DNA PRCA IVIG;20 50g/ IVIG PVB19AIHA steroid 15 20mg/day 2003
More information2) Goetz, A., Tsuneishi, N.: Application of molecular filter membranes to the bacteriological analysis of water, J. Am. Water Works Assn., 43 (12): 943-969,1951. 3) Clark, H.F. et al.: The membrane filter
More informationTOEIC(R) Newsletter
June 2009 No.105 TOEIC Newsletter TOEIC Newsletter No.105 June 2009 2 TOEIC Newsletter No.105 June 2009 3 4 TOEIC Newsletter No.105 June 2009 TOEIC Newsletter No.105 June 2009 5 6 TOEIC Newsletter No.105
More information血糖高いのは朝食後のため検査項目 下限値上限値 単位名称 9 月 3 日 9 月 6 日 9 月 15 日 9 月 18 日 9 月 21 日 9 月 24 日 9 月 28 日 10 月 1 日 10 月 3 日 10 月 5 日 10 月 9 日 10 月 12 日 10 月 15 日 10 月
検査項目 下限値上限値 単位名称 7 月 9 日 7 月 10 日 7 月 11 日 7 月 12 日 7 月 13 日 7 月 17 日 7 月 20 日 7 月 23 日 7 月 25 日 7 月 27 日 7 月 30 日 8 月 3 日 8 月 6 日 8 月 8 日 8 月 10 日 8 月 12 日 8 月 15 日 8 月 17 日 8 月 20 日 8 月 22 日 8 月 24 日
More informationハピタス のコピー.pages
Copyright (C) All Rights Reserved. 10 12,500 () ( ) ()() 1 : 2 : 3 : 2 4 : 5 : Copyright (C) All Rights Reserved. Copyright (C) All Rights Reserved. Copyright (C) All Rights Reserved. Copyright (C) All
More informationCopyright 2008 All Rights Reserved 2
Copyright 2008 All Rights Reserved 1 Copyright 2008 All Rights Reserved 2 Copyright 2008 All Rights Reserved 3 Copyright 2008 All Rights Reserved 4 Copyright 2008 All Rights Reserved 5 Copyright 2008 All
More informationDS-30
NPD4633-00 JA ...6... 6... 6... 6... 6... 7... 7... 7... 7... 8... 8...9...10...11...11...13 Document Capture Pro Windows...13 EPSON Scan Mac OS X...14 SharePoint Windows...16 Windows...16...17 Document
More information/ / A/ B 16/17 COPD 18mcg COPD COPD COPD 1
11 1 -------------------- 19 205.117/205.128 14/15 205.126A/205.126B 16/17 COPD 18mcg COPD 11.1 11.1.1 COPD 100 19 205.227 COPD 1 FEV1.0 %FEV1.0 70% 1 FEV1.0 / FVC 70% 2 1 200 3 40 COPD 1 10mg ACE 1 1
More informationPX-504A
NPD4537-00 ...6... 6... 9 Mac OS X...10 Mac OS X v10.5.x v10.6.x...10 Mac OS X v10.4.11...13...15...16...16...18...19...20!ex...20 /...21 P.I.F. PRINT Image Framer...21...22...26...26...27...27...27...31
More informationuntitled
Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb
More information九州支部卒後研修会症例
血液検査研修会 ( 第 25 回 ) 検査の異常から探る! 造血器腫瘍へのアプローチ 症例提示 症例 1~8 - 症例発表者 - 症例 1 藤崎恵熊本医療センター 症例 2 荒木敏造浜の町病院 症例 3 古城剛鹿児島大学病院 症例 4 佐々木高太郎都城健康サービスセンター 症例 5 矢田佳愛 大分県立病院 症例 6 下田博臣 健康保険諫早総合病院 症例 7 堤陽子 佐賀県医療センター好生館 症例 8
More information1 2 2 ANCA pouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - ' UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, cm 61
1 2 2 ANCApouci immune IgG C3 ANCA 68 '01 '02 7 UN 14mg/dl, Cr 0.7 mg/dl, -, - '03 2 3 31 UN 45mg/dl, Cr 2.4 mg/dl, Ht 29.5%, 4+, 3+ 4 14 156.0 cm 61.5 kg 36.9 158/92 mmhg 90 1. ANCA 2. 3. IgG4 deposit
More information訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書
1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....
More informationI 4 1 4 1...................................... 5 2........................................... 5 3.............................................. 6 2 6 1.............................................. 7
More information21 5 I C T J-Doit High risk Risk 20 7 21 34,324 30,858 38,735 26,800 27,490 20,472 18,533 20,096 14,913 14,931 488 470 491 435 446 10 t-pa intervention t-pa interventionclipping simulator subspecialty
More informationE Societe de Pathologie Infectieuse de Langue Francaise (, 1991) E Spanish Thoracic Society (1992) E American Thoracic Society (ATS : 1993. ü ù2001 ) E British Thoracic Society (1993, ü è2001 ) E Canadian
More informationFA
29 28 15 1985 1993 The process of the labor negotiations of the Japan Professional Baseball Players Association, 1985 1993 ABE Takeru Graduate School of Social Science, Hitotsubashi University Abstract
More informationuntitled
c OR 21 OR 1. 21 21 IoT OR OR OR 260 8672 1 8 1 OR 2. 2.1 public health [1] communicable (infectious) diseases vehicle burden HIV/AIDS (SARS) 258 60 Copyright c by ORSJ. Unauthorized reproduction of this
More informationEPSON PX-503A ユーザーズガイド
NPD4296-00 ...6... 6...10 Mac OS X...11 Mac OS X v10.5.x v10.6.x...11 Mac OS X v10.4.x...15...18...19...19...21...22...23!ex...23 /...24 P.I.F. PRINT Image Framer...24...25...28...28...29...29...30...33
More informationuntitled
2005 10 13 Dr. RGA 19602000 10 Australian Institute of of Health and and Welfare 2004 ABS Cat. Cat. No. No. 3201.0; AIHW National Population Database 1875 2 211997 8 122164 http://www.wowzone.com/calment.htm
More informationMicrosoft Word - 平成24年度医学部卒業試験問題-2.docx
24 2012.10.25 13:00 15 00 5 2 10 20 60 80 110 10 1 6 7 /kg 1 12 20 30:2 AED 3 1 2 119 2 2 2 X X SpO 90% 60mmHg Primary Survey FAST CT 90% 100mmHg FAST 1 2L FAST(Focused assessment with sonography for trauma)
More information<4D F736F F D208C C9F8DB8926C82A982E782DD82BD89C193FC8ED282CC8C928D4E8FF391D482C98AD682B782E992B28DB895AA90CD2E646F6378>
28 6 IT 26 1 326 4,499 433 40-74 100cm 2 100cm 2 BMI25kg/m 2 85cm90cm 85cm90cm BMI25kg/m 2 130mmHg 140mmHg 85mmHg 90mmHg 150mg/dL 300mg/dL HDL 39mg/dL 34mg/dL LDL 120mg/dL 140mg/dL 100mg/dL 126mg/dL HbA1c
More information14UNAIDS HIV 39% i 9 ii9iii UNAIDS x.9x.9x1= ?? UNAIDS % 77%8% 44.7x.77x.8x1=
DeCEMBER, 17 No.34 HIV 169-73 1-1-1-13TEL 3-5937-4413:3 19:3 FAX 3-5937-443E-mail info@janpplus.jp http://janpplus.jp/!9-9-9!... 1-3 POSITIVE HIV/AIDS UNAIDS!... 4-5 JaNP+HIV Cafe Bar an opportunity...
More information<4D F736F F D2095BD90AC E93785F8C C9F8DB8926C82A982E782DD82BD89C193FC8ED282CC8C928D4E8FF391D482C98AD682B782E992B28DB895AA90CD2E646F6378>
29 7 IT 27 339 5,199 464 40-74 100cm 2 100cm 2 BMI25kg/m 2 85cm90cm 85cm90cm BMI25kg/m 2 130mmHg 140mmHg 85mmHg 90mmHg 150mg/dL 300mg/dL HDL 39mg/dL 34mg/dL LDL 120mg/dL 140mg/dL 100mg/dL 126mg/dL HbA1c
More informationDS-70000/DS-60000/DS-50000
NPD4647-02 JA ...5...7...8 ADF...9... 9 ADF...10...11...13...15 Document Capture Pro Windows...15 EPSON Scan Mac OS X...16 SharePoint Windows...18 Windows...18...19 Windows...19 Mac OS X...19...20...23...23
More information<8C9F8DB85F3338E4508CB495612E786C73>
尿 検 査 初 回 登 録 前 回 調 査 時 から 変 更 なし 追 加 データあり 随 時 尿 蛋 白 ( 定 性 ) - - - 糖 ( 定 性 ) - - - 潜 血 ( 定 性 ) - - - 項 目 に が 付 与 されている 場 合 : 該 当 の 項 目 は 1/5 尿 検 査 血 球 算 定 初 回 登 録 前 回 調 査 時 から 変 更 なし 追 加 データあり WBC ( )
More informationMicrosoft, Windows Microsoft Corporation
Copyright 2000-2002 T&D Corporation. All rights reserved. 2002.07 16004194030 Microsoft, Windows Microsoft Corporation This Modem Logger is designed for use in Japan only and can not be used in any other
More informationPX-434A/PX-404A
NPD4534-00 ...6... 6...10 Mac OS X...11 Mac OS X v10.5.x v10.6.x...11 Mac OS X v10.4.11...15...18...19...19...21...22!ex...22 /...23 P.I.F. PRINT Image Framer...23...24...26...27...27...28...28...31 Web...31...31...35...35...35...37...37...37...39...39...40...43...48
More information1000 Copyright(C)2009 All Rights Reserved - 2 -
1000 Copyright(C)2009 All Rights Reserved - 1 - 1000 Copyright(C)2009 All Rights Reserved - 2 - 1000 Copyright(C)2009 All Rights Reserved - 3 - 1000 Copyright(C)2009 All Rights Reserved - 4 - 1000 Copyright(C)2009
More information橡災害.PDF
1 2 3 4 5 6 7 8 9 10 11 12 2.1 2.2 2.2.1 13 2.2.2 2.2.3 14 2.3 2.3.1 2.3.2 all or nothing 2.4. 2.4.1 15 i) ii) iii) iv) 2.5 2.4.2 2.2 2.5 2.5.1 16 2.5.2 2.6 2.6.1 2.4 2.6.2 2.6.3 2.6.4 17 18 3.2.1 Hazard
More informationPowerPoint プレゼンテーション
Copyright 2008 KOZO KEIKAKU ENGINEERING Inc. All Rights Reserved. http://www.kke.co.jp Copyright 2008 KOZO KEIKAKU ENGINEERING Inc. All Rights Reserved. http://www.kke.co.jp 1 Copyright 2008 KOZO KEIKAKU
More information- 9 91, (2006)
Case study level Ma Management of testicular cancer - 9 91, 10 0.7 2.4 (2006) 20 30 20 20-40 AFP -hcg -hcg AFP TNM T ptx pt0 ptis pt1 / pt2 / pt3 / pt4 / N NX N0 N1 2cm 1 2cm N2 2cm 5cm 1 5cm N3 5cm TNM
More informationPX-403A
NPD4403-00 ...6... 6...10 Mac OS X...11 Mac OS X v10.5.x v10.6.x...11 Mac OS X v10.4.x...15...18...19...19...21...22!ex...22 /...23 P.I.F. PRINT Image Framer...23...24...27...27...28...28...28...32 Web...32...32...35...35...35...37...37...37...39...39...40...43...46
More information20 15 14.6 15.3 14.9 15.7 16.0 15.7 13.4 14.5 13.7 14.2 10 10 13 16 19 22 1 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2,500 59,862 56,384 2,000 42,662 44,211 40,639 37,323 1,500 33,408 34,472
More informationI? 3 1 3 1.1?................................. 3 1.2?............................... 3 1.3!................................... 3 2 4 2.1........................................ 4 2.2.......................................
More information- 2 -
- 2 - - 3 - (1) (2) (3) (1) - 4 - ~ - 5 - (2) - 6 - (1) (1) - 7 - - 8 - (i) (ii) (iii) (ii) (iii) (ii) 10 - 9 - (3) - 10 - (3) - 11 - - 12 - (1) - 13 - - 14 - (2) - 15 - - 16 - (3) - 17 - - 18 - (4) -
More information2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4 4 4 2 5 5 2 4 4 4 0 3 3 0 9 10 10 9 1 1
1 1979 6 24 3 4 4 4 4 3 4 4 2 3 4 4 6 0 0 6 2 4 4 4 3 0 0 3 3 3 4 3 2 4 3? 4 3 4 3 4 4 4 4 3 3 4 4 4 4 2 1 1 2 15 4 4 15 0 1 2 1980 8 4 4 4 4 4 3 4 2 4 4 2 4 6 0 0 6 4 2 4 1 2 2 1 4 4 4 2 3 3 3 4 3 4 4
More information1 (1) (2)
1 2 (1) (2) (3) 3-78 - 1 (1) (2) - 79 - i) ii) iii) (3) (4) (5) (6) - 80 - (7) (8) (9) (10) 2 (1) (2) (3) (4) i) - 81 - ii) (a) (b) 3 (1) (2) - 82 - - 83 - - 84 - - 85 - - 86 - (1) (2) (3) (4) (5) (6)
More information日本呼吸器学会雑誌第44巻第1号
β β l β β Table1 Laboratorydataonadmission Hematology WBC 9,910/μl neut 72.4% lym 20.2% eos 0.9% mon 6.1% baso 0.4% RBC 491 10 4 /μl Hb 16.8g/dl Ht 48.3% PLT 29.8 10 4 /μl ESR 3mm/hr Biochemistry TP Alb
More informationLDL HbA1c6. 5% AST51 ALT51 - GT LDL180 1, mmHg 85mmHg 150mg/dL HDL 40mg/dL 100mg/dL HbA1c 5.6% mmhg mg/dl mg/
30 7 IT 28 335 704 4 16 40-74 1 3 1100cm 2 100cm 2 BMI25kg/m 2 285cm 90cm 385cm 90cm BMI25kg/m 2 130mmHg 140mmHg 85mmHg 90mmHg 150mg/dL 300mg/dL HDL 39mg/dL 34mg/dL LDL 120mg/dL 140mg/dL 100mg/dL 126mg/dL
More informationエレクトーンのお客様向けiPhone/iPad接続マニュアル
/ JA 1 2 3 4 USB TO DEVICE USB TO DEVICE USB TO DEVICE 5 USB TO HOST USB TO HOST USB TO HOST i-ux1 6 7 i-ux1 USB TO HOST i-mx1 OUT IN IN OUT OUT IN OUT IN i-mx1 OUT IN IN OUT OUT IN OUT IN USB TO DEVICE
More information在外教育施設派遣教員安全対策資料 在外教育施設派遣教員安全対策資料
1. 1. 1.1.1. 1.1.2. 1.1.3. 1.1.4. 1.1.5. 1. 2. 1. 3. 1. 4. 1-1 1-2 1-3 2. 1. 2. 2. 2. 3. 2. 4. 2.4.1. 2.4.2. 2-1 2. 5. 2. 6. 2.6.1. 2.6.2. 2.6.3. 2.6.4. 2.6.5. 2. 7. 2.7.1. 2.7.2. 2.7.3. 2.7.4. 2. 8. 2.
More information日赤 No.35☆/7.河相
2 64 2 Mucosa-Associated Lymphoid TissueMALT T γ- 1 Key words T 1 2 64 47 54 60 MALT 63 T MALT 6062-8 63 1 T MALT 63 CHOP 2 35 28 30 28 75 μg 200 mg 20 mg 200 mg 400 mg/80 mg 2 35 mg 1 2 150 mg 200 mg
More informationindd
60 4 2010 197 症例報告 1 1 1 2 2 2 2 3 4 1 2 3 4 2010 7 27 2010 9 24 Case of a Young Adult Male Complicated with Ischemic Colitis EMI OGATA 1, TAKERU WAKATSUKI 1, HIROAKI SAKAMOTO 1, NATSUMI SAKAMOTO 2, OSAMU
More information/ B B ( ) ( -298) VL VH( ) Very Low( ) Very High( ) ( 10 2 %) (g/l) ( 10 2 %) 0.75 ( 10 2 %) 0.15 ( 10 2 %)
/ B B ( ) ( -298) VL VH( ) Very Low( ) Very High( ) (10 2 %) 0.32 0.55 0.37 0.55 95 165 115 185 (10 2 %) 0.75 (10 2 %) 0.15 (10 2 %) 0.10 10 2 % 0.10 10 2 % 0.15 10 2 % 0.10 Bands(10 2 %) 0.10 (10 9 75
More information5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU
CT MRI CSFCSF CSF CSF CSF CSF CSF (cisternal puncture) CSF 20-23G 90 (20-23G) : CSF
More informationiPhone/iPad接続マニュアル
/ JA 2 3 USB 4 USB USB i-ux1 USB i-ux1 5 6 i-mx1 THRU i-mx1 THRU 7 USB THRU 1 2 3 4 1 2 3 4 5 8 1 1 9 2 1 2 10 1 2 2 6 7 11 1 2 3 4 5 6 7 8 12 1 2 3 4 5 6 13 14 15 WPA Supplicant Copyright 2003-2009, Jouni
More informationたたら製鉄についてのまとめ
65 1229 1570 5 3 5 2769 1876 1889 9 1892 1927-73 - - 1619 131 2 5500 43 194 1889 1955-1617 3 2 3 1186 2 9 15 1165-74 - 596 300 200 4 888 4 888 11 3 8892 10 2 969 708781782888 729 749 859 877 3 947 3 1523
More informationTable 1 Detection bacterial strains used in this study *1; Methicillin resistant strains(mrsa)
Key words: PCR, ribosomal RNA, bacterial contamination Table 1 Detection bacterial strains used in this study *1; Methicillin resistant strains(mrsa) PCR法 Fig. 1 Agarose gel ribosomal DNA Amplification
More information高脂血症の検査
35 30 Buffy coatbuffy coat EDTA Na Na Ca RBC Hb Ht WBC Plt ESR TP Alb CRP GOTGPTLDH BUN Cre UA HbA1C TC TG NaKClCaPFe B12 36 RBC 410530 /μl 380480 /μl Hb 13.517.6g/dL 11.315.2g/dL Ht 3648% 3443% MCV MCH
More information日本ロータリー史
2680 RI ( ) RI 1971 50 1 2 FUKUSHIMA Kisaji 38 1912 Southern Products William 1915 1920 KISOJO 3 1918 10 1919 1920 1 Albert Adams 4 In Japan authority to organize Rotary in Tokyo, its capital, has been
More information